C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/06/2001	US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation
11/06/2001	US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease
11/06/2001	US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
11/06/2001	US6312689 Antibodies or antigens
11/06/2001	US6312688 Tyrosine-phosphatase-related protein
11/06/2001	US6312685 Red blood cells covalently bound with two different polyethylene glycol derivatives
11/06/2001	US6312684 Antitumor agents
11/06/2001	US6312683 Equine infectious anemia virus vectors
11/06/2001	US6312682 Retroviral vectors
11/01/2001	WO2001081616A2 Method for screening of microorganisms under nutrient limited conditions
11/01/2001	WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance
11/01/2001	WO2001081600A2 Transgenic plants
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081552A1 Patterned substrates and methods for nerve regeneration
11/01/2001	WO2001081551A2 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001	WO2001081550A1 Method of constructing three-dimensional cell clusters from cultured cells
11/01/2001	WO2001081549A2 Hepatocyte lineage cells derived from pluripotent stem cells
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	WO2001081409A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081405A2 Methods and compositions for the prevention and treatment of anemia
11/01/2001	WO2001081400A1 Nk-2 homeobox transcription factor
11/01/2001	WO2001081387A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080865A2 Joint repair using mesenchymal stem cells
11/01/2001	WO2001080833A1 Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
11/01/2001	WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001	WO2001080760A1 Method for expansion of epithelial stem cells
11/01/2001	WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv
11/01/2001	WO2001080626A1 Nucleic acids that control plant development
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001034807A3 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2?
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001032839A3 Medium for preparing dedifferentiated cells
11/01/2001	WO2001029189A3 Synthetic substrate for tissue formation
11/01/2001	WO2001009176A3 Mammalian cytokines; related reagents
11/01/2001	WO2000046383A8 Method of modulating metabolite biosynthesis in recombinant cells
11/01/2001	WO2000043523A3 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate)
11/01/2001	WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
11/01/2001	WO2000039276A9 Microbial transformation method for the preparation of an epothilone
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000034442A3 Application of shear flow stress to smooth muscle cells for the production of implantable structures
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010037514 Oil containing triglyceride having a 1,3-dierycoyl 2-oleoyl glycerol content of at least 50%; transgenic plants for producing seeds; lubricant additives; hydraulic oils
11/01/2001	US20010037513 Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells
11/01/2001	US20010036925 Genetic engineering
11/01/2001	US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036664 Graft-versus-host disease
11/01/2001	US20010036663 Selective expansion of target cell populations
11/01/2001	US20010036656 Forming viruses
11/01/2001	US20010036655 Vaccine
11/01/2001	US20010036628 Inoculation, culture product, calibration
11/01/2001	US20010036624 Liquid phase; capturing, recovering, removal
11/01/2001	US20010036462 Enhancing immunology response
11/01/2001	US20010035132 Electrical coupling between chamber parts in electronic device processing equipment
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	EP1144596A3 Application of shear flow stress to smooth muscle cells for the production of implantable structures
11/01/2001	CA2690018A1 Methods and compositions for the prevention and treatment of anemia
11/01/2001	CA2407455A1 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	CA2407449A1 Novel compounds
11/01/2001	CA2407424A1 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001	CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	CA2407081A1 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	CA2407077A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	CA2406736A1 Nucleic acids that control plant development
11/01/2001	CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2405985A1 Nk-2 homeobox transcription factor
11/01/2001	CA2405983A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001	CA2405961A1 Bispecific molecules and uses thereof
11/01/2001	CA2405364A1 Transgenic plants
11/01/2001	CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	CA2403916A1 Viral vectors for use in monitoring hiv drug resistance
10/2001
10/31/2001	EP1149916A2 Defective Adenoviruses and corresponding transcomplementant cell lines
10/31/2001	EP1149915A1 Modification of gene expression in transgenic plants
10/31/2001	EP1149913A1 Cytokine immunoconjugates
10/31/2001	EP1149912A2 Polyhydroxyalkanoate synthase and gene encoding the same
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001	EP1149900A1 Solution for preserving human liver cells, preserved cells, and their use
10/31/2001	EP1149899A1 Culture medium for avian totipotential embryonic cells

1 ... 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 ... 1827